Statistical analysis showed a significant increase in serum GLUT-1 in glioblastoma subgroup either prior to or following RT in comparison to healthy volunteers (p1 = 0.002 and < 0.001 respectively). This evidence concerns the gene SLC2A1 and glioblastoma.